fullerene c60 has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Corwin, FD; Dorn, HC; Esker, AR; Fatouros, PP; Gibson, HW; Reid, JE; Shu, C; Sim, JH; Sun, M; Wang, C; Xu, W; Zhang, J | 1 |
| Harhaji, L; Isakovic, A; Markovic, I; Markovic, Z; Nikolic, N; Raicevic, N; Todorovic-Markovic, B; Trajkovic, V; Vranjes-Djuric, S | 1 |
2 other study(ies) available for fullerene c60 and Glial Cell Tumors
| Article | Year |
|---|---|
Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.
Topics: Animals; Contrast Media; Diffusion; Female; Fullerenes; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Peroxides; Protons; Rats; Solubility; Water | 2009 |
Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Fullerenes; Glial Fibrillary Acidic Protein; Glioma; Humans; Lipid Peroxidation; Mitogen-Activated Protein Kinases; Nanoparticles; Rats; Reactive Oxygen Species | 2007 |